Full Paper
H, Ar), 8.63 (s, 1 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = 67.5,
1 H, ≡ CH), 4.93 (s, 2 H, CH2), 6.23 (s, 1 H, C=CH), 6.83 and 7.42 (AA′
84.2, 97.8, 116.9, 123.8, 125.5, 125.9, 127.6, 127.8, 127.9, 128.8, 130.4, BB′ syst., 2 H + 2 H, Ar), 7.52 (m, 4 H, Ar), 7.62 (br. s, 1 H, NH), 7.83
130.7, 138.4, 157.1, 173.7, 177.1 ppm. C24H17BF2INO2 (527.11): calcd. (m, 2 H, Ar), 8.07 (m, 2 H, Ar), 8.60 (s, 1 H, Ar) ppm. 13C NMR (75 MHz,
C 54.69, H 3.25, N 2.66; found C 54.65, H 3.21, N 2.65.
CDCl3): δ = 55.7, 67.4, 83.0, 114.5, 117.2, 123.8, 125.9, 127.8, 127.9,
128.3, 128.8, 130.4, 130.7, 133.7, 138.2, 157.5, 173.7, 177.2 ppm.
2,2-Difluoro-6-[(4-iodophenoxy)methyl]-4-(phenanthren-9-yl)-
2,3-dihydro-1,3,2-oxazaborinin-1-ium-2-uide (7b): Yellow solid
C26H18BF2NO2 (425.23): calcd. C 73.44, H 4.27, N 3.29; found C 73.45,
H 4.22, N 3.25.
(1.21 g, 64 %); m.p. 170–175 °C (cyclohexane/ethyl acetate). IR:
1
νNH = 3333 cm–1. H NMR (300 MHz, CDCl3): δ = 4.88 (s, 2 H, CH2),
6-[(4-Ethynylphenoxy)methyl]-2,2-difluoro-4-(phenanthren-9-
˜
6.26 (s, 1 H, C=CH), 6.75 and 7.61 (AA′BB′ syst., 2 H + 2 H, 4-iodophe- yl)-2,3-dihydro-1,3,2-oxazaborinin-1-ium-2-uide (9b): Yellow
nyl), 7.59 (s, 1 H, NH), 7.77 (m, 5 H, Ar), 7.88 (d, J = 7 Hz, 1 H, Ar), solid (0.45 g, 88 %); m.p. 150–152 °C (cyclohexane/ethyl acetate). IR:
1
7.98 (d, J = 7 Hz, 1 H, Ar), 8.72 (d, J = 7 Hz, 1 H, Ar), 8.79 (d, J =
ν = 3369 (NH), 3304 (CH) cm–1. H NMR (300 MHz, CDCl3): δ = 3.05
˜
7 Hz, 1 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = 67.4, 84.2, 96.2,
(s, 1 H, ≡ CH), 4.92 (s, 2 H, CH2), 6.27 (s, 1 H, C=CH), 6.88 and 7.42
116.9, 122.7, 123.5, 124.9, 127.0, 127.6, 127.7, 127.9, 128.3, 129.1, (AA′BB′ syst., 2 H + 2 H, Ar), 7.75 (m, 4 H, Ar), 7.72 (m, 1 H, Ar), 7.88
129.7, 130.7, 131.4, 138.5, 157.2, 172.9, 176.4 ppm. C24H17BF2INO2
(527.11): calcd. C 54.69, H 3.25, N 2.66; found C 54.70, H 3.26, N
2.64.
(br. s, 1 H, NH), 7.90 (d, J = 7 Hz, 1 H, Ar), 8.73 (d, J = 7 Hz, 1 H, Ar),
8.79 (d, J = 7 Hz, 1 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = 67.4,
83.0, 96.1, 114.6, 122.7, 123.5, 124.9, 127.6, 127.7, 127.9, 128.2, 129.1,
129.6, 129.7, 133.7, 157.6, 172.9, 176.5 ppm. C26H18BF2NO2 (425.23):
calcd. C 73.44, H 4.27, N 3.29; found C 73.43, H 4.29, N 3.27.
Sonogashira Coupling of Boron Complexes 7a and 7b: Boron
complex 7a or 7b (1.6 g, 3 mmol) was dissolved in anhydrous DMF
(6 mL) along with distilled triethylamine (0.7 mL, 5 mmol) and eth-
ynyltrimethylsilane (0.56 mL, 4 mmol) in the presence of CuCl
(0.16 g, 10 mol-%) and Pd(PPh)4 (0.16 g, 10 mol-%). The mixture was
stirred for 2 h under an inert atmosphere. DCM was added, and the
mixture was washed with a saturated solution of NH4Cl (3 × 50 mL)
and then brine (3×). The combined organic phases were dried with
anhydrous Na2SO4, and the solvent was evaporated. The resulting
black oily residue was purified by column chromatography to give
the functionalized boron complex 8a or 8b.
Cycloaddition of Benzyl Azide to Compounds 9a: To boron com-
plex 9a (0.1 g, 0.2 mmol) dissolved in anhydrous DCM (40 mL) was
added benzyl azide (0.4 mL, 0.2 mmol), as the mixture was stirred
under an inert atmosphere. A catalytic amount of CuSO4·10H2O was
added to the solution along with the same quantity of sodium
ascorbate. The mixture was then allowed to react at room tempera-
ture for 2 h. DCM was then added, and the resulting mixture was
washed with brine (3 × 50 mL). The organic phase was dried with
anhydrous Na2SO4, and the solvent was evaporated. The resulting
yellow oily residue was purified by column chromatography to give
cycloadduct 10.
4-(Anthracen-9-yl)-2,2-difluoro-6-({4-[(trimethylsilyl)ethynyl]-
phenoxy}methyl)-2,3-dihydro-1,3,2-oxazaborinin-1-ium-2-uide
= 3296 cm–1 1H NMR
.
4-(Anthracen-9-yl)-6-{[4-(1-benzyl-1H-1,2,3-triazol-4-yl)phen-
oxy]methyl}-2,2-difluoro-2,3-dihydro-1,3,2-oxazaborinin-1-
ium-2-uide (10): Yellow solid (0.07 g, 60 %); m.p. 175–178 °C
(8a): Yellow oil (1.19 g, 80 %). IR: ν
˜
NH
(300 MHz, CDCl3): δ = 0.26 (s, 9 H, TMS), 4.94 (s, 2 H, CH2), 6.24 (s,
1 H, C=CH), 6.83 and 7.41 (AA′BB′ syst., 2 H + 2 H, Ar), 7.56 (m, 4 H,
Ar), 7.72 (br. s, 1 H, NH), 7.82 (m, 2 H, Ar), 8.09 (m, 2 H, Ar), 8.62 (s,
1 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = –0.10, 67.4, 97.8, 114.4,
123.8, 125.9, 127.6, 127.8, 127.9, 128.8, 130.3, 130.7, 133.5, 157.2,
173.7, 177.2 ppm. C29H26BF2NO2Si (497.41): calcd. C 70.02, H 5.27,
N 2.82; found C 70.05, H 5.22, N 2.85.
(cyclohexane/ethyl acetate). IR: νC=N
= .
1633 cm–1 1H NMR
˜
(300 MHz, [D6]DMSO): δ = 5.05 (s, 2 H, CH2), 5.63 (s, 2 H, CH2), 6.08
(s, 1 H, C=CH), 7.08 and 7.76 (AA′BB′ syst., 2 H + 2 H, Ar), 7.36 (m,
5 H, Ar), 7.60 (m, 4 H, Ar), 7.72 (m, 2 H, Ar), 8.21 (m, 2 H, Ar), 8.54
(s, 1 H, Ar), 8.85 (s, 1 H, NH), 11.15 (s, 1 H, NH) ppm. 13C NMR
(75 MHz, [D6]DMSO): δ = 53.0, 67.0, 97.6, 115.2, 120.8, 123.8, 124.2,
125.9, 126.5, 127.2, 127.7, 127.9, 128.1, 128.2, 128.8, 129.5, 130.4,
136.1, 146.4, 157.0, 172.0, 175.4 ppm. C33H25BF2N4O2 (558.39): calcd.
C 70.98, H 4.51, N 10.03; found C 70.95, H 4.52, N 10.05.
2,2-Difluoro-4-(phenanthren-9-yl)-6-({4-[(trimethylsilyl)-
ethynyl]ohenoxy}methyl)-2,3-dihydro-1,3,2-oxazaborinin-1-
1
ium-2-uide (8b): Yellow oil (1.15 g, 77 %). IR: νNH = 3301 cm–1. H
˜
NMR (300 MHz, CDCl3): δ = 0.27 (s, 9 H, TMS), 4.87 (s, 2 H, CH2),
6.23 (s, 1 H, C=CH), 6.87 and 7.79 (AA′BB′ syst., 2 H + 2 H, Ar), 7.56
(m, 4 H, Ar), 7.6–7.9 (m, 7 H, Ar), 7.86 (br. s, 1 H, NH), 8.68 (m, 1 H,
Ar), 8.74 (m, 1 H, Ar) ppm. 13C NMR (75 MHz, CDCl3): δ = –0.07,
67.3, 96.2, 114.5, 122.6, 123.4, 125.0, 127.0, 127.1, 127.6, 127.7, 128.2,
128.3, 128.5, 128.6, 130.6, 131.3, 133.6, 157.3, 172.8, 176.2 ppm.
C29H26BF2NO2Si (497.41): calcd. C 70.02, H 5.27, N 2.82; found C
70.00, H 5.26, N 2.84.
Acknowledgments
Financial support was provided by the University of Pavia, the
Itakian Ministero dell'Università e della Ricerca (MIUR) (PRIN
2011, CUP: F11J12000210001), and COST Action CM1004. A
warm thank you is also given to Steroid S. p. A. for the generous
research grant.
Deprotection of the Triple Bond – Preparation of Compounds
9a and 9b: To boron complex 8a or 8b (0.6 g, 1.2 mmol) dissolved
in anhydrous diethyl ether (30 mL) was added TBAF (1
M in THF,
Keywords: Fluorescent probes · Boron · Nitrogen
heterocycles · Cycloaddition · UV/Vis spectroscopy
1.2 mL, 1.2 mmol), and the mixture was stirred under an inert at-
mosphere for 10 min. DCM was then added, and the resulting mix-
ture was washed with water. The organic phase was dried with
anhydrous Na2SO4, and the solvent was evaporated. The resulting
yellow oily residue was purified by column chromatography to give
the deprotected boron complex 9a or 9b.
[1] P. Caramella, P. Grünanger, in: 1,3-Dipolar Cycloaddition Chemistry (Ed.: A.
Padwa), John Wiley & Sons, New York, 1984, vol. 1, p. 291–392.
[2] C. Grundmann, J. M. Dean, J. Org. Chem. 1965, 30, 2809–2812.
[3] P. Grünanger, P. Vita Finzi, in: Isoxazoles, part 1 (Ed.: A. Weissberger), John
Wiley & Sons, New York, 1991, vol. 1, p. 341–648.
[4] a) M. Nitta, T. Kobayashi, J. Chem. Soc. Perkin Trans. 1 1985, 1401–1406;
b) S. I. Sviridov, A. A. Vasil'ev, S. V. Shorshnev, Tetrahedron 2007, 63,
12195–12201; c) S. Kovacs, Z. Novak, Tetrahedron 2013, 69, 8987–8993.
4-(Anthracen-9-yl)-6-[(4-ethynylphenoxy)methyl]-2,2-difluoro-
2,3-dihydro-1,3,2-oxazaborinin-1-ium-2-uide (9a): Yellow solid
(0.39 g, 77 %); m.p. 164–168 °C (cyclohexane/ethyl acetate). IR: ν =
˜
1
3322 (NH), 3276 (CH) cm–1. H NMR (300 MHz, CDCl3): δ = 3.03 (s,
Eur. J. Org. Chem. 2016, 821–829
828
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim